Skip to main content
Erschienen in: Neurological Sciences 2/2015

01.02.2015 | Original Article

Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations

verfasst von: Raffaele Iorio, Mario Sabatelli, Alessandra Del Grande, Giulia Bisogni, Valentina Damato, Domenico Plantone, Alessandro Marti, Giovanni Frisullo, Angela Romano, Paolo Maria Rossini, Marco Luigetti

Erschienen in: Neurological Sciences | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

IgM-related neuropathy generally presents as a late-onset demyelinating polyneuropathy with predominant sensory loss and ataxia. However, we recently reported the clinical, neurophysiological and pathological findings from our cohort and identified in about a third of patients an atypical phenotype. We analyzed by flow cytometry the different lymphocytes subsets in the peripheral blood of patients affected by IgM-related neuropathy, chronic inflammatory demyelinating polyneuropathy (CIDP), monoclonal gammopathy of undetermined significance and healthy subjects, to investigate whether different immunological patterns may differentiate the classical phenotype from atypical forms. IFN-gamma producing CD4+ and CD8+ T lymphocytes, as well as CD4+ and CD8+ T cells expressing T-bet (T-helper type 1, Th1) were increased in CIDP patients. The percentage of circulating CD4+ and CD8+ T cells producing IL-10 as well as the percentage of CD19+ cells expressing Blimp-1 were higher in patients with IgM-neuropathy. We did not find any significant differences in the different lymphocytes subsets in the IgM-related neuropathy between patients with classical and atypical phenotype. Th1 cells are increased in CIDP patients while a T helper type 2-phenotype seems to prevail in patients with IgM-neuropathy. Further studies involving a larger patient population are needed to evaluate if different lymphocytes subset may be involved in different clinical phenotypes of IgM-related neuropathy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G (2000) Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 123:710–717CrossRefPubMed Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G (2000) Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 123:710–717CrossRefPubMed
2.
Zurück zum Zitat Trojaborg W, Hays AP, Van Den Berg L, Younger DS, Latov N (1995) Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 18:730–735CrossRefPubMed Trojaborg W, Hays AP, Van Den Berg L, Younger DS, Latov N (1995) Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 18:730–735CrossRefPubMed
3.
Zurück zum Zitat Luigetti M, Padua L, Mazza S, Rossini PM, Sabatelli M, Lo Monaco M (2013) Clinical-neurophysiological correlations in a series of patients with IgM-related neuropathy. Clin Neurophysiol 124:1899–1903CrossRefPubMed Luigetti M, Padua L, Mazza S, Rossini PM, Sabatelli M, Lo Monaco M (2013) Clinical-neurophysiological correlations in a series of patients with IgM-related neuropathy. Clin Neurophysiol 124:1899–1903CrossRefPubMed
4.
Zurück zum Zitat Nobile-Orazio E, Barbieri S, Baldini L, Marmiroli P, Carpo M, Premoselli S et al (1992) Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Acta Neurol Scand 85:383–390CrossRefPubMed Nobile-Orazio E, Barbieri S, Baldini L, Marmiroli P, Carpo M, Premoselli S et al (1992) Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Acta Neurol Scand 85:383–390CrossRefPubMed
5.
Zurück zum Zitat Hafler DA, Johnson D, Kelly JJ, Panitch H, Kyle R, Weiner HL (1986) Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics. Neurology 36:75–88CrossRefPubMed Hafler DA, Johnson D, Kelly JJ, Panitch H, Kyle R, Weiner HL (1986) Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics. Neurology 36:75–88CrossRefPubMed
6.
Zurück zum Zitat Luigetti M, Conte A, Montano N, Del Grande A, Madia F, Lo Monaco M et al (2012) Clinical and pathological heterogeneity in a series of 31 patients with IgM-related neuropathy. J Neurol Sci 319:75–80CrossRefPubMed Luigetti M, Conte A, Montano N, Del Grande A, Madia F, Lo Monaco M et al (2012) Clinical and pathological heterogeneity in a series of 31 patients with IgM-related neuropathy. J Neurol Sci 319:75–80CrossRefPubMed
7.
Zurück zum Zitat Baldini L, Nobile-Orazio E, Guffanti A, Barbieri S, Carpo M, Cro L et al (1994) Peripheral neuropathy in IgM monoclonal gammopathy and Waldenström’s macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component. Am J Hematol 45:25–31CrossRefPubMed Baldini L, Nobile-Orazio E, Guffanti A, Barbieri S, Carpo M, Cro L et al (1994) Peripheral neuropathy in IgM monoclonal gammopathy and Waldenström’s macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component. Am J Hematol 45:25–31CrossRefPubMed
8.
Zurück zum Zitat Luigetti M, Frisullo G, Laurenti L, Conte A, Madia F, Profice P et al (2010) Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström’s macroglobulinaemia. J Neurol Sci 291:89–91CrossRefPubMed Luigetti M, Frisullo G, Laurenti L, Conte A, Madia F, Profice P et al (2010) Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström’s macroglobulinaemia. J Neurol Sci 291:89–91CrossRefPubMed
9.
Zurück zum Zitat Vital C, Deminière C, Bourgouin B, Lagueny A, David B, Loiseau P (1985) Waldenström’s macroglobulinemia and peripheral neuropathy: deposition of M-component and kappa light chain in the endoneurium. Neurology 35:603–606CrossRefPubMed Vital C, Deminière C, Bourgouin B, Lagueny A, David B, Loiseau P (1985) Waldenström’s macroglobulinemia and peripheral neuropathy: deposition of M-component and kappa light chain in the endoneurium. Neurology 35:603–606CrossRefPubMed
10.
Zurück zum Zitat Grassi MP, Clerici F, Perin C, Borella M, Gendarini A, Quattrini A et al (1998) Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient. Ital J Neurol Sci 19:229–233CrossRefPubMed Grassi MP, Clerici F, Perin C, Borella M, Gendarini A, Quattrini A et al (1998) Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient. Ital J Neurol Sci 19:229–233CrossRefPubMed
11.
Zurück zum Zitat Thomas FP, Lovelace RE, Ding XS, Sadiq SA, Petty GW, Sherman WH et al (1992) Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IGM monoclonal gammopathy. Muscle Nerve 15:891–898CrossRefPubMed Thomas FP, Lovelace RE, Ding XS, Sadiq SA, Petty GW, Sherman WH et al (1992) Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IGM monoclonal gammopathy. Muscle Nerve 15:891–898CrossRefPubMed
12.
Zurück zum Zitat Bajada S, Mastaglia FL, Fisher A (1980) Amyloid neuropathy and tremor in Waldenström’s macroglobulinaemia. Arch Neurol 37:240–242CrossRefPubMed Bajada S, Mastaglia FL, Fisher A (1980) Amyloid neuropathy and tremor in Waldenström’s macroglobulinaemia. Arch Neurol 37:240–242CrossRefPubMed
13.
Zurück zum Zitat Iwashita H, Argyrakis A, Lowitzsch K, Spaar FW (1974) Polyneuropathy in Waldenström’s macroglobulinaemia. J Neurol Sci 21:341–354CrossRefPubMed Iwashita H, Argyrakis A, Lowitzsch K, Spaar FW (1974) Polyneuropathy in Waldenström’s macroglobulinaemia. J Neurol Sci 21:341–354CrossRefPubMed
14.
Zurück zum Zitat Gironi M, Saresella M, Marventano I, Guerini FR, Gatti A, Antonini G et al (2010) Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy. Muscle Nerve 42:864–870CrossRefPubMed Gironi M, Saresella M, Marventano I, Guerini FR, Gatti A, Antonini G et al (2010) Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy. Muscle Nerve 42:864–870CrossRefPubMed
15.
Zurück zum Zitat Nijkamp FP, Pamham MJ (eds) (2011) Principles of immunopharmacology: 3rd revised and extended edition Basel: Birkhäuser Basel Nijkamp FP, Pamham MJ (eds) (2011) Principles of immunopharmacology: 3rd revised and extended edition Basel: Birkhäuser Basel
16.
Zurück zum Zitat Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A et al (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51–62CrossRefPubMed Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A et al (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51–62CrossRefPubMed
17.
Zurück zum Zitat Luigetti M, Madia F, Conte A, Tonali P, Sabatelli M (2010) Neuropathy with predominant small fibre involvement associated with abnormal anti-MAG titre. Intern Med 49:2627–2629CrossRefPubMed Luigetti M, Madia F, Conte A, Tonali P, Sabatelli M (2010) Neuropathy with predominant small fibre involvement associated with abnormal anti-MAG titre. Intern Med 49:2627–2629CrossRefPubMed
18.
Zurück zum Zitat Kawagashira Y, Kondo N, Atsuta N, Iijima M, Koike H, Katsuno M et al (2010) IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy. Muscle Nerve 42:433–435CrossRefPubMed Kawagashira Y, Kondo N, Atsuta N, Iijima M, Koike H, Katsuno M et al (2010) IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy. Muscle Nerve 42:433–435CrossRefPubMed
19.
Zurück zum Zitat Kimura J (1989) Electrodiagnosis in disease of the nerve and muscle: principles and practice. FA Davis, Philadelphia, pp 103–138 Kimura J (1989) Electrodiagnosis in disease of the nerve and muscle: principles and practice. FA Davis, Philadelphia, pp 103–138
20.
Zurück zum Zitat Merolli A, Luigetti M, Modoni A, Masciullo M, Lucia Mereu M, Lo Monaco M (2013) Persistence of abnormal electrophysiological findings after carpal tunnel release. J Reconstr Microsurg 29:511–516CrossRefPubMed Merolli A, Luigetti M, Modoni A, Masciullo M, Lucia Mereu M, Lo Monaco M (2013) Persistence of abnormal electrophysiological findings after carpal tunnel release. J Reconstr Microsurg 29:511–516CrossRefPubMed
21.
Zurück zum Zitat Luigetti M, Quaranta D, Modoni A, Mereu ML, Lo Monaco M (2012) Nerve conduction studies of the sural nerve: normative data from a single-center experience. Clin Neurophysiol 123:1891–1892CrossRefPubMed Luigetti M, Quaranta D, Modoni A, Mereu ML, Lo Monaco M (2012) Nerve conduction studies of the sural nerve: normative data from a single-center experience. Clin Neurophysiol 123:1891–1892CrossRefPubMed
22.
Zurück zum Zitat Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I et al (2010) European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. Eur J Neurol 17:356–363CrossRefPubMed Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I et al (2010) European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. Eur J Neurol 17:356–363CrossRefPubMed
23.
Zurück zum Zitat Madia F, Frisullo G, Nociti V, Conte A, Luigetti M, Del Grande A et al (2009) pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 14:107–117CrossRefPubMed Madia F, Frisullo G, Nociti V, Conte A, Luigetti M, Del Grande A et al (2009) pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 14:107–117CrossRefPubMed
Metadaten
Titel
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations
verfasst von
Raffaele Iorio
Mario Sabatelli
Alessandra Del Grande
Giulia Bisogni
Valentina Damato
Domenico Plantone
Alessandro Marti
Giovanni Frisullo
Angela Romano
Paolo Maria Rossini
Marco Luigetti
Publikationsdatum
01.02.2015
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 2/2015
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-014-1935-x

Weitere Artikel der Ausgabe 2/2015

Neurological Sciences 2/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.